Insider · CIK 0001442372
Stephen L Sabba
director
Files at LGND (LIGAND PHARMACEUTICALS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +1,209 | $0.00 | $0 | 33,793 | Jun 10, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,783 | $0.00 | $0 | 5,783 | Jun 10, 2025 |
| Apr 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock | +2,406 | $52.30 | $126k | 32,584 | Apr 16, 2025 |
| Apr 1, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -2,406 | $0.00 | $0 | 0 | Apr 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.